J 2017

MAGERI: Computational pipeline for molecular-barcoded targeted resequencing

SHUGAY, Mikhail, A.R. ZARETSKY, D.A. SHAGIN, I.A. SHAGINA, I.A. VOLCHENKOV et. al.

Basic information

Original name

MAGERI: Computational pipeline for molecular-barcoded targeted resequencing

Authors

SHUGAY, Mikhail (643 Russian Federation, belonging to the institution), A.R. ZARETSKY (643 Russian Federation), D.A. SHAGIN (643 Russian Federation), I.A. SHAGINA (643 Russian Federation), I.A. VOLCHENKOV (643 Russian Federation), A.A. SHELENKOV (643 Russian Federation), Mikhail LEBEDIN (643 Russian Federation, belonging to the institution), D.V. BAGAEV (643 Russian Federation), S. LUKYANOV (643 Russian Federation) and Dmitriy CHUDAKOV (643 Russian Federation, guarantor, belonging to the institution)

Edition

PLoS Computational Biology, SAN FRANCISCO, PUBLIC LIBRARY SCIENCE, 2017, 1553-734X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10609 Biochemical research methods

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.955

RIV identification code

RIV/00216224:14740/17:00100339

Organization unit

Central European Institute of Technology

UT WoS

000402889500008

Keywords in English

CIRCULATING TUMOR DNA; THERAPEUTIC RESPONSE; IMMUNE REPERTOIRES; COLORECTAL-CANCER; SOMATIC MUTATION; SEQUENCING ERROR; RARE MUTATIONS; SOLID TUMORS; GENOME; PLASMA

Tags

Tags

International impact, Reviewed
Změněno: 13/3/2018 14:07, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Unique molecular identifiers (UMIs) show outstanding performance in targeted high-throughput resequencing, being the most promising approach for the accurate identification of rare variants in complex DNA samples. This approach has application in multiple areas, including cancer diagnostics, thus demanding dedicated software and algorithms. Here we introduce MAGERI, a computational pipeline that efficiently handles all caveats of UMI-based analysis to obtain high-fidelity mutation profiles and call ultra-rare variants. Using an extensive set of benchmark datasets including gold-standard biological samples with known variant frequencies, cell-free DNA from tumor patient blood samples and publicly available UMI-encoded datasets we demonstrate that our method is both robust and efficient in calling rare variants. The versatility of our software is supported by accurate results obtained for both tumor DNA and viral RNA samples in datasets prepared using three different UMI-based protocols.

Links

LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
633592, interní kód MU
Name: APERIM - Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy (Acronym: APERIM)
Investor: European Union, APERIM - Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy, Health, demographic change and wellbeing (Societal Challenges)